Young, James B.

Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man

Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,143

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

MacDonald, M. R., Petrie, M. C., Varyani, F., Ostergren, J., Michelson, E. L., Young, J. B., Solomon, S. D., Granger, C. B., Swedberg, K., Yusuf, S., et al. (2008) · European Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 694

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Solomon, S. D., Dobson, J., Pocock, S., Skali, H., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Young, J. B., Michelson, E. L., et al. (2007) · Circulation

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 681

Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial

Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., Love, T. E., Aronow, W. S., Adams, K. F., & Gheorghiade, M. (2006) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 605

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

O'Connor, C. M., Abraham, W. T., Albert, N. M., Clare, R., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., Yancy, C. W., Young, J. B., & Fonarow, G. C. (2008) · American Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 430

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Ducharme, A., Swedberg, K., Pfeffer, M. A., Cohen-Solal, A., Granger, C. B., Maggioni, A. P., Michelson, E. L., McMurray, J. J. V., Olsson, L., Rouleau, J. L., et al. (2006) · American Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 352

Bariatric surgery and cardiovascular outcomes: a systematic review

Vest, A. R., Heneghan, H. M., Agarwal, S., Schauer, P. R., & Young, J. B. (2012) · Heart

Bariatric Surgery and OutcomesCardiovascular Function and Risk Factors

Cited by 336

Reduced sympathetic nervous system responsivity associated with the relaxation response.

Hoffman, J. W., Benson, H., Arns, P. A., Stainbrook, G. L., Landsberg, L., Young, J. B., & Gill, A. (1982) · Science

Heart Rate Variability and Autonomic ControlStress Responses and Cortisol

Cited by 272

Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure

Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2008) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 257

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

Anderson, C., Teo, K., Gao, P., Arima, H., Dans, A., Unger, T., Commerford, P., Dyal, L., Schumacher, H., Pogue, J., et al. (2011) · The Lancet Neurology

Renin-Angiotensin System StudiesDementia and Cognitive Impairment Research

Cited by 216

Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

Greenberg, B. H., Abraham, W. T., Albert, N. M., Chiswell, K., Clare, R., Stough, W. G., Gheorghiade, M., O'Connor, C. M., Sun, J. L., Yancy, C. W., et al. (2007) · American Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 196

A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS

Domanski, M. J., Krause-Steinrauf, H., Massie, B. M., Deedwania, P., Follmann, D., Kovar, D., Murray, D., Oren, R., Rosenberg, Y., Young, J., et al. (2003) · Journal of Cardiac Failure

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 176

Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

Desai, A. S., Swedberg, K., McMurray, J. J. V., Granger, C. B., Yusuf, S., Young, J. B., Dunlap, M. E., Solomon, S. D., Hainer, J. W., Olofsson, B., et al. (2007) · Journal of the American College of Cardiology

Potassium and Related DisordersHeart Failure Treatment and Management

Cited by 170

Beta-blocker use and outcomes among hospitalized heart failure patients

Butler, J., Young, J. B., Abraham, W. T., Bourge, R. C., Adams, K. F., Clare, R., & O’Connor, C. (2006) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 106

influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study

Ward, K. D., Sparrow, D., Landsberg, L., Young, J. B., Vokonas, P. S., & Weiss, S. T. (1996) · Journal of Hypertension

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 92

Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries

Smyth, A., Dehghan, M., O'Donnell, M., Anderson, C., Teo, K., Gao, P., Sleight, P., Dagenais, G., Probstfield, J. L., Mente, A., et al. (2015) · Neurology

Nutritional Studies and DietDementia and Cognitive Impairment Research

Cited by 85

Worsening Renal Function and Outcome in Heart Failure Patients with Reduced and Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment: Data from the CHARM-Study Programme

Damman, K., Solomon, S. D., Pfeffer, M. A., Swedberg, K., Yusuf, S., Young, J. B., Rouleau, J. L., Granger, C. B., & McMurray, J. J. V. (2016) · European Journal of Heart Failure

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 75

Patterns of β-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic

Gupta, R., Tang, W. H. W., & Young, J. B. (2004) · American Heart Journal

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 45

Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial

Pantalone, K. M., Smolarz, B. G., Ramasamy, A., Baz Hecht, M., Harty, B. J., Rogen, B., Griebeler, M. L., Borukh, E., Young, J. B., & Burguera, B. (2021) · JAMA Network Open

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 31